BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29271911)

  • 1. Resveratrol-Induced Changes in MicroRNA Expression in Primary Human Fibroblasts Harboring Carnitine-Palmitoyl Transferase-2 Gene Mutation, Leading to Fatty Acid Oxidation Deficiency.
    Aires V; Delmas D; Djouadi F; Bastin J; Cherkaoui-Malki M; Latruffe N
    Molecules; 2017 Dec; 23(1):. PubMed ID: 29271911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts.
    Bastin J; Lopes-Costa A; Djouadi F
    Hum Mol Genet; 2011 May; 20(10):2048-57. PubMed ID: 21378393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells.
    Djouadi F; Aubey F; Schlemmer D; Bastin J
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1791-7. PubMed ID: 15613406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts.
    Aires V; Delmas D; Le Bachelier C; Latruffe N; Schlemmer D; Benoist JF; Djouadi F; Bastin J
    Orphanet J Rare Dis; 2014 Jun; 9():79. PubMed ID: 24898617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new AMPK activator, GSK773, corrects fatty acid oxidation and differentiation defect in CPT2-deficient myotubes.
    Boufroura FZ; Le Bachelier C; Tomkiewicz-Raulet C; Schlemmer D; Benoist JF; Grondin P; Lamotte Y; Mirguet O; Mouillet-Richard S; Bastin J; Djouadi F
    Hum Mol Genet; 2018 Oct; 27(19):3417-3433. PubMed ID: 30007356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of CPT2 deficiency.
    Fontaine M; Kim I; Dessein AF; Mention-Mulliez K; Dobbelaere D; Douillard C; Sole G; Schiff M; Jaussaud R; Espil-Taris C; Boutron A; Wuyts W; Acquaviva C; Vianey-Saban C; Roland D; Joncquel-Chevalier Curt M; Vamecq J
    Mol Genet Metab; 2018 Apr; 123(4):441-448. PubMed ID: 29478820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia.
    Habib A; Azize NAA; Rahman SA; Yakob Y; Suberamaniam V; Nazri MIBA; Abdullah Sani H; Ch'ng GS; Yin LH; Olpin S; Lock-Hock N
    Clin Biochem; 2021 Dec; 98():48-53. PubMed ID: 34626609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy.
    Pereyra AS; Hasek LY; Harris KL; Berman AG; Damen FW; Goergen CJ; Ellis JM
    J Biol Chem; 2017 Nov; 292(45):18443-18456. PubMed ID: 28916721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine palmitoyltransferase deficiencies.
    Bonnefont JP; Demaugre F; Prip-Buus C; Saudubray JM; Brivet M; Abadi N; Thuillier L
    Mol Genet Metab; 1999 Dec; 68(4):424-40. PubMed ID: 10607472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
    Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
    Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of iPSC-derived myocytes from a patient with carnitine palmitoyltransferase II deficiency.
    Yasuno T; Osafune K; Sakurai H; Asaka I; Tanaka A; Yamaguchi S; Yamada K; Hitomi H; Arai S; Kurose Y; Higaki Y; Sudo M; Ando S; Nakashima H; Saito T; Kaneoka H
    Biochem Biophys Res Commun; 2014 May; 448(2):175-81. PubMed ID: 24780397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myopathy due to carnitine palmitoyltransferase II deficiency: updating genetic aspects of the first publication in Brazil.
    Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Rodrigues PRDVP; Arndt RC; Scola RH; Werneck LC
    Arq Neuropsiquiatr; 2024 Feb; 82(2):1-4. PubMed ID: 38395422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblasts.
    Yao M; Cai M; Yao D; Xu X; Yang R; Li Y; Zhang Y; Kido H; Yao D
    PLoS One; 2015; 10(3):e0119936. PubMed ID: 25781464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a fast method for the measurement of carnitine palmitoyltransferase 2 activity in lymphocytes by tandem mass spectrometry as confirmation for newborn screening.
    Tucci S; Behringer S; Sturm M; Grünert SC; Spiekerkoetter U
    J Inherit Metab Dis; 2019 Sep; 42(5):850-856. PubMed ID: 30957255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of fatty acid oxidation in carnitine palmitoyl transferase 2-deficient cultured skin fibroblasts by bezafibrate.
    Djouadi F; Bonnefont JP; Thuillier L; Droin V; Khadom N; Munnich A; Bastin J
    Pediatr Res; 2003 Oct; 54(4):446-51. PubMed ID: 12840153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low C0 and normal C16 and C18:1 masking the diagnosis of carnitine palmitoyltransferase II deficiency including a novel CPT2 variant: A case report.
    Wang S; Diao C; Leng J
    Arch Pediatr; 2024 Jan; 31(1):85-88. PubMed ID: 38168614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful orthotopic heart transplantation in CPTII deficiency.
    Arnold GL; Yester J; McCracken E; Feingold BD; Vockley J
    Mol Genet Metab; 2021 Jun; 133(2):182-184. PubMed ID: 34020866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Adipose Fatty Acid Oxidation Does Not Potentiate Obesity at Thermoneutrality.
    Lee J; Choi J; Aja S; Scafidi S; Wolfgang MJ
    Cell Rep; 2016 Feb; 14(6):1308-1316. PubMed ID: 26854223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CPT2 gene mutation analysis and prenatal diagnosis in a family with carnitine palmitoyltransferase II deficiency].
    Tan JQ; Chen DY; Li WG; Li ZT; Huang JW; Yan TZ; Cai R
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Dec; 18(12):1282-1285. PubMed ID: 27974123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octanoate is differentially metabolized in liver and muscle and fails to rescue cardiomyopathy in CPT2 deficiency.
    Pereyra AS; Harris KL; Soepriatna AH; Waterbury QA; Bharathi SS; Zhang Y; Fisher-Wellman KH; Goergen CJ; Goetzman ES; Ellis JM
    J Lipid Res; 2021; 62():100069. PubMed ID: 33757734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.